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Abstract
Transcription factors are proteins that regulate gene expression by binding to cis-regulatory sequences such as promoters
and enhancers. In embryonic stem (ES) cells, binding of the transcription factors OCT4, SOX2 and NANOG is essential to
maintain the capacity of the cells to differentiate into any cell type of the developing embryo. It is known that transcription
factors interact to regulate gene expression. In this study we show that combinatorial binding is strongly associated with co-
localization of the transcriptional co-activator Mediator, H3K27ac and increased expression of nearby genes in embryonic
stem cells. We observe that the same loci bound by Oct4, Nanog and Sox2 in ES cells frequently drive expression in early
embryonic development. Comparison of mouse and human ES cells shows that less than 5% of individual binding events for
OCT4, SOX2 and NANOG are shared between species. In contrast, about 15% of combinatorial binding events and even
between 53% and 63% of combinatorial binding events at enhancers active in early development are conserved. Our
analysis suggests that the combination of OCT4, SOX2 and NANOG binding is critical for transcription in ES cells and likely
plays an important role for embryogenesis by binding at conserved early developmental enhancers. Our data suggests that
the fast evolutionary rewiring of regulatory networks mainly affects individual binding events, whereas ‘‘gene regulatory
hotspots’’ which are bound by multiple factors and active in multiple tissues throughout early development are under
stronger evolutionary constraints.
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Introduction
Embryonic stem (ES) cells are derived from the inner cell mass
of the blastocyst [1]. During the course of normal development,
implantation of the blastocyst results in further differentiation into
distinct cell types of the three primary germ layers that will later
form the tissues and organs of the developing embryo [2]. This
pluripotent state makes ES cells a unique in vitro cellular model
system to study early embryogenesis. At the core of the regulatory
network that maintains this state is a set of transcription factors
amongst which OCT4 seems to play a key role [3,4]. OCT4 has
been shown to co-occupy many regulatory sites together with
SOX2, NANOG and the co-activator p300 [5]. The potency of
these transcription factors is demonstrated by their ability to
induce pluripotency in mouse and human somatic cells. This was
achieved by the ectopic expression of OCT4 and SOX2 together
with either KLF4 and c-MYC, or NANOG and LIN28 [6,7,8].
The pivotal step in inducing and maintaining the pluripotent
state occurs at the level of genomic DNA by the binding of
transcription factors and co-factors that activate and repress gene
expression. The largest fraction of the genome is non-coding with
many non-coding elements being highly conserved. Even though it
is expected that many of these elements harbor transcription factor
binding sites and may act as enhancers, current understanding of
the interplay between transcription factors and regulatory
elements within the genome is limited. ChIP-Seq data pinpoints
transcription factor binding sites not only in predefined regions
such as promoters but in an unbiased way genome-wide.
However, the high sensitivity comes along with a low specificity
that makes identification of functional sites challenging. Never-
theless, in order to understand self renewal and pluripotency at the
level of transcriptional regulation, it is crucial to identify a reliable
set of regulatory elements that actively contribute to the regulation
of gene expression in pluripotent cells such as embryonic stem cells
and induced pluripotent stem cells.
ES cells reflect a very early time point of development. Many
genes which are important for early embryogenesis have a
conserved function in mouse and human. OCT4, SOX2 and
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state both in mouse and human ES cells [3,9]. However, despite
their conserved function, where these transcription factors bind
seems to be highly species-specific: A comparison of mouse and
human ES cells revealed that only about 5% of binding events of
the key pluripotency factors OCT4 and NANOG are conserved at
orthologous genomic locations in both species [10]. A study of
genome-wide binding in liver tissue reported the same with only
about 7% conserved binding events for the liver transcription
factors CEBP and HNF4 between mouse and human [11]. These
data show how fast cis-regulatory elements can evolve compared
to coding sequence, yet we do not know what discriminates
conserved from non-conserved binding events. Genome-wide
comparisons give average values over all observed binding events.
These numbers are influenced by many factors such as the choice
of control, processing of the data, and p-value and false discovery
rate cutoffs. The biological impact of individual binding events
may therefore be very different, ranging from non-functional
binding to binding events which are essential for the regulation of
associated genes and the survival of the individual [12]. For that
reason, the fraction of conserved binding events is currently
unknown for a highly confident set of enhancers.
It is well known that transcription factors interact to regulate
gene expression. It has been shown in mouse ES (mES) cells that
combinatorial binding of Oct4, Sox2 and Nanog is associated with
increased expression of nearby genes [5]. Here, we use
combinatorial binding to increase the specificity of the ChIP-Seq
technology in order to identify a highly confident set of regulatory
elements. We investigate the association of these elements with the
transcriptional co-activator Mediator, histone modifications and
gene expression, to test whether the interactions of transcription
factors provide a link between binding and activation of their
target genes.
Studies in Drosophila suggest that the combination of binding
sites plays an important role during the evolution of gene
regulatory elements [13], however the effect of combinatorial
binding on evolution in mammals is currently unknown. Analysis
of mammalian genome sequences suggested that developmentally
active enhancers are highly conserved [14]. Integration of
genome-wide binding data from mouse and human ES and
embryonal carcinoma (EC/NCCIT) cells and mouse develop-
mental tissues allows us for the first time to study the evolution of
gene regulation in the light of combinatorial binding and
developmental activity in mammalian cells using an in vitro system.
Our analysis indicates that both characteristics contribute to the
evolutionary constraint on regulatory elements and suggests that
the integrated data represents an essential set of conserved
enhancers that links pluripotency with early embryonal develop-
ment.
Results
We mapped genome-wide binding data of Oct4, Sox2 and
Nanog in mES cells to study the effect of combinatorial binding.
We further mapped binding data from the transcriptional co-
activators p300 and Mediator subunits Med1 and Med12 which
are important to activate gene expression by linking regulatory
elements with the basal transcriptional machinery. We additionally
mapped binding data from Cohesin (subunits Smc1 and Smc3)
and CTCF which are involved in gene regulation through DNA
loop formation [15]. Using MACS [16] we identified sets of
potential binding events (ChIP-Seq ‘‘peaks’’) for every factor. We
discarded all peaks with a p-value.1e-05 and peaks that were
detected in the control data (‘‘full data set’’). As a control for the
influence of the p-value cutoff, we additionally analyzed the data
using only the top 10% of peaks (sorted by p-value) from every
experiment (‘‘stringent data set’’). We intentionally did not choose
a false discovery rate (FDR) cutoff, since the FDR (as estimated by
MACS) is heavily dependent on the control data [16] which is
lacking for some experiments (see supplementary Figures S1, S2,
S4, S9 for a comparison of different cutoffs). To compare genome-
wide binding in mouse and human ES cells we processed data
from human cells in the same way (see supplementary Table S1 for
a complete listing of accession numbers, mapped reads and
number of peaks). Important insights have been obtained from
studies using ChIP-on-chip data [3,17], however due to its
limitation to promoter regions we did not integrate this data into
our analysis. The complete data used in this study is available at
the European Nucleotide Archive (supplementary Table S1) and
can be accessed at http://enhancer.molgen.mpg.de, where we
provide a human and mouse genome browser displaying genome-
wide binding profiles, major histone modifications and RNA-seq
data [18]. Figure 1 shows the aligned SOX2 locus in the mouse and
human genomes along with the data used in this study.
Combinatorial binding detects functional interactions
As a first step toward analyzing combinatorial binding we
calculated the similarity of the genome-wide binding profiles for all
factors (Figure 2A–B, see Materials and Methods). These
similarities identify three distinct clusters: Enhancer binding
(Oct4, Nanog, Sox2), Insulator binding (CTCF, Cohesin subunits
Smc1 and Smc3a) and transcriptional co-activation (Mediator
subunits Med1 and Med12). Interestingly, pairwise distances from
genome-wide data on DNA-protein interactions reproduce known
protein-protein interactions [19] (Figure 2B): CTCF interacts with
Cohesin at insulator elements, Oct4, Sox2 and Nanog interact at
enhancers, and Mediator plays a central role by integrating signals
from distant regulatory elements and Cohesin. To test whether the
amount of overlap of transcription factor binding that we observed
can be expected by chance, we calculated the overlap of position-
randomized binding events. Overall, the overlap observed in the
data is much higher than expected by chance (Figure 2C–D).
Author Summary
The mammalian body is composed of hundreds of distinct
cell types. During embryogenesis, this diversity is created
by multiple cell fate decisions and differentiation events.
Embryonic stem (ES) cells provide the in vitro model to
study differentiation and early development. Their plurip-
otent state is maintained by transcription factors such as
OCT4, SOX2 and NANOG which bind to regulatory
elements within the genome. Understanding the interplay
between transcription factor binding, gene expression and
cellular differentiation is key to understanding the
development of the mammalian embryo. In this study
we find that combinatorial binding of OCT4, SOX2 and
NANOG in ES cells identifies enhancers which are
associated with active transcription. We observe that these
enhancers also frequently show activity at later develop-
mental stages. Using data from mouse and human ES cells
we find that these combinatorially bound enhancers which
are active in pluripotent cells and development show
extraordinarily high levels of binding conservation (.50%).
Our analysis suggests that these conserved ‘‘gene regula-
tory hotspots’’ integrate the transcriptional network that
promotes pluripotency into the gene regulatory networks
that promote cell fate decisions and differentiation during
early embryonic development.
Combinatorial Binding in Human and Mouse ES Cells
PLoS Computational Biology | www.ploscompbiol.org 2 December 2011 | Volume 7 | Issue 12 | e1002304These results support the notion that the combination of binding
events reflects functional interactions between the proteins
themselves.
The Mediator complex co-localizes at combinatorially
bound loci
Combinatorial binding of Oct4, Sox2 and Nanog in mES cells
has been reported to influence gene expression [5], however the
exact mechanism is unclear. Since the Mediator complex has a
central role in linking enhancers with activation of gene expression
[15,20,21], we examined whether the binding combination of
Oct4, Sox2 and Nanog influences co-localization of the Mediator
subunits Med1 and Med12 at enhancers. For all possible
combinations we calculated the fraction of loci where Med1 or
Med12 co-localizes (Figure 3A). Since these loci vary by number
and size, we calculated the expected overlap from randomized
data sets (Hyper geometric test, see Materials and Methods).
Between 5% and 30% of loci bound by Oct4, Nanog or Sox2
individually co-localize with Med1 or Med12 (Figure 3A). In
contrast, loci bound by Oct4, Nanog and Sox2 simultaneously
(further referred to as combinatorially bound loci) co-localize
much more frequently with Med1 (44%, z-score 155.9) and
Med12 (59%, z-score 215.5).
Co-localization of DNA binding proteins could be unspecific,
for example due to binding at open chromatin regions (see [12] for
a review). Unspecific co-localization is not accounted for with the
theoretical expected overlap. To control for this effect we need to
calculate co-localization of factors which we know are unrelated.
Figure 2 shows that CTCF largely binds to different regions than
the enhancer binding proteins Oct4, Sox2 and Nanog [22],
therefore CTCF co-localization should be depleted at combina-
torially bound loci. We observe that CTCF overlaps with
individual binding events of Sox2 and Oct4. In contrast, CTCF
co-localization is significantly depleted at loci bound by Oct4,
Sox2 and Nanog simultaneously (z=210.5). This suggests that
combinatorial binding reduces unspecific co-localization and
confirms the association of the Mediator complex with combina-
torial bound loci.
The strength of the ChIP-Seq signal (‘‘binding intensity’’) is
likely to hint at important binding sites. We calculated the
association of Mediator with Oct4, Sox2 and Nanog independent
of their combination for a data set that only includes the top 10%
peaks (sorted by p-value) for every experiment. In this set, CTCF
co-localization is depleted showing that a stringent p-value cutoff
efficiently reduces unspecific overlap (Figure 3A). However,
combinatorial binding is a much more sensitive indicator for
Mediator co-localization, as only 16% of Oct4, Sox2 and Nanog
loci show Med1 co-localization when we look into high intensity
peaks (25% with Med12), compared to 44% for the combinato-
rially bound loci in the full data set (59% for Med12). The binding
combination has a similar influence in both the stringent and the
full data set (supplementary Figure S2), re-assuring us that the
particular choice of p-value cutoff is of little importance in this
analysis.
Since Mediator occupies many promoters in the genome,
transcription factors that bind preferentially to promoter regions
would be expected to show co-localization with Med1 or Med12.
To test whether the interaction between Oct4, Sox2 and Nanog
occurs mainly at the promoter thereby causing the observed
Mediator co-localization, we calculated the fraction of promoter
and enhancer bound loci for all binding combinations. The
majority of loci bound by Oct4, Sox2 and Nanog are at distant
regulatory elements (61%–97%), even when Mediator co-locali-
zation can be observed (Figure 3B). This shows that the increased
overlap at combinatorially bound loci reflects specific binding at
distant regulatory elements and is not caused by simultaneous
occupation of the proximal promoter of actively transcribed genes.
The strong association of combinatorial binding with Mediator
suggests that Mediator bound loci are functionally different from
loci without Mediator binding. We used histone modification
profiles and gene expression of nearby genes to test for functional
differences. Combinatorially bound loci occupied by Mediator are
strongly enriched in H3K27ac, a mark for active enhancers,
compared to loci without Mediator co-localization (Figure 4) [23].
To test the effect of Mediator binding on gene expression, we
performed a gene-set enrichment analysis (GSEA) [24] using
Figure 1. Overview of genome-wide binding data in human
and mouse embryonic stem cells and embryonal carcinoma
cells. Shown is the locus of the SOX2 gene in the human genome (top),
along with mapped reads for OCT4, SOX2, NANOG and p300. Individual
experiments are shown separately. The orthologous locus in the mouse
genome is aligned at the bottom along with mapped reads from the
individual experiments.
doi:10.1371/journal.pcbi.1002304.g001
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after 14 days [25]. We sorted all genes according to their
difference between ES cells and differentiated cells (Figure 5A) and
then calculated the enrichment score for genes near loci bound by
Oct4, Sox2 and Nanog with Med1/Med12 (group 1) and without
Med1/Med12 (group 2). Group 1 shows a significant enrichment
in genes expressed in stem cells (Enrichment scores 0.43, p-value
0.0) (Figure 5B). Interestingly, group 2 shows a stronger
enrichment in genes which are expressed in differentiated cells
(Figure 5B, enrichment score 20.3, p=0.05), suggesting that
Oct4, Nanog and Sox2 might co-occupy poised enhancers. Both
histone profiles and gene expression data support the notion that
combinatorial binding identifies enhancers in embryonic stem cells
while Mediator co-localization determines their activity.
Combinatorial binding identifies developmental
enhancers in embryonic stem cells
Binding of Oct4, Sox2 and Nanog frequently occurs near
developmental genes [3] and gene expression data suggests that
genes near combinatorial binding events are indeed up-regulated
Figure 2. Co-localization within the genome identifies known protein interaction. (A) Clustering of genome-wide binding profiles from
mES cells based on the number of shared binding events identifies three main classes: Enhancer binding (Oct4, Sox2, Nanog), Insulator binding (CTCF,
Smc1, Smc3) and Mediator associated binding (Med1, Med12, Nipbl). (B) Protein interaction network inferred from genome-wide binding data. Edges
represent the pairwise similarities with a z-score above a threshold. (C–D) The number of overlapping experiments is much higher than expected by
chance, both for mouse binding data (mm9, D) and human binding data together with the aligned mouse data (hg19, C). Randomized data sets show
only very few cases where more than five experiments overlap (black line). The data used in this study shows a much stronger overlap with many loci
where binding was detected in more than five experiments (red line).
doi:10.1371/journal.pcbi.1002304.g002
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Nanog together with Med1 or Med12 are likely to act as enhancers in
embryonic stem cells. However, the function of loci near inactive
genes is unclear. Since many of these genes are active during
development, we tested whether Oct4, Sox2 and Nanog co-occupied
loci act as early developmental enhancers. We used a set of tissue-
specific enhancers obtained from mouse embryos at day e11.5
[14,26], a stage where neither Oct4 nor Nanog is expressed.
Nevertheless, 9% (z=27.5) of combinatorially bound loci in ES cells
overlap with developmental enhancers. Enhancers that are active in
development show an enrichment of H3K27ac in neuronal
progenitor cells (supplementary Figure S3), supporting that these
indeed become active after differentiation. It is likely that some of
these regulatory elements are in a poised state. Poised enhancers have
been identified in embryonic stem cells by unique chromatin
modification signatures [23,27], however, this is the first evidence
for active participation of Oct4, Sox2 and Nanog in this poised state.
Our analysis suggests that binding of pluripotency-associated
transcription factors at developmental enhancers might be a key
feature of the ability of pluripotent stem cells to differentiate into
distinctcelltypes.Usageofsuch‘‘sharedenhancers’’,whichareactive
in multiple stages during differentiation, links the gene regulatory
networks of embryonic stem cells with the networks for early
development at the level of transcriptional regulation.
Combinatorial binding events are conserved in evolution
Using data from human ES cells, we investigated whether
combinatorial binding can further help in discriminating con-
Figure 3. Mediator co-localizes with Oct4, Sox2 and Nanog at combinatorially bound enhancers. (A) Bars indicate the fraction of loci
where Med1, Med12 and CTCF binding can be observed, depending on the combination of Oct4, Sox2 and Nanog, indicated by boxes below. Dark
boxes indicate binding, white boxes indicate no binding (‘‘AND’’ relation), light grey boxes with ‘‘v’’ indicate binding of at least one factor (‘‘OR’’
relation). Both Med1 and Med12 preferentially co-localize at loci bound by Oct4, Sox2 and Nanog simultaneously. Combinatorial binding is more
sensitive than a stringent control of false positives: The 10% most significant peaks are significantly associated with Med1 and Med12, however, the
overall fraction is much lower compared to combinatorially bound loci. CTCF serves as a control to estimate unspecific binding. (B) The majority of
loci bound by Oct4, Sox2 and Nanog are more than 1000 bp away from the nearest transcription start sites for all possible combinations (indicated by
boxes above). Mediator co-localization mainly occurs at distant regulatory sites, showing that the increased overlap of Med1/Med12 at
combinatorially bound loci is not caused by promoter specific co-localization.
doi:10.1371/journal.pcbi.1002304.g003
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mapped genome-wide binding data for OCT4, SOX2 and
NANOG from human ES cells and OCT4 from human
embryonal carcinoma (EC) cells using the same procedure as
described above (supplementary Table S1 for Accession numbers,
mapped reads and number of peaks). EC cells are the malignant
counterpart of ES cells [28], however they possess a distinct set of
binding sites, extending the repertoire of potential OCT4 bound
loci. We used whole-genome alignments to assign binding events
in mES cells to their orthologous loci in the human genome,
retaining only those that could be aligned uniquely [29]. We call a
binding event ‘‘conserved’’ if binding of the same factor can be
observed at the aligned loci in the human and mouse genome.
For every combination of OCT4, SOX2 and NANOG binding
we calculated the fraction of conserved binding events for every
factor (Figure 6A). Indeed, combinatorial binding is a good
predictor for conservation: Less than 5% of individual binding
events are conserved, which is less than expected. In contrast,
about 15% of binding events at loci which are simultaneously co-
occupied by OCT4, SOX2 and NANOG in hES cells show
conserved binding of the respective transcription factor in mES
cells (z-scores=33.6, 41.3, 31.1, Figure 6A). We additionally
calculated the number of transcription factors that bind at
conserved loci in mouse for all combinations of OCT4, SOX2
and NANOG in human cells (Figure 6B). 53% of combinatorial
binding events in human are simultaneously occupied by Oct4,
Sox2 and Nanog in mouse, showing that combinatorial binding is
likely to be a conserved property of regulatory elements in ES cells.
Since CTCF does not show significant association with
combinatorially bound loci in mouse (Figure 2, 3), we use CTCF
binding in mES cells to estimate unspecific conservation. CTCF
binding is significantly depleted at combinatorially bound loci
(Figure 6A, z-score=26.8), showing that the increased conserva-
tion is specific to the combination of transcription factors. In
contrast, CTCF binding can be observed at higher levels for all
other binding combinations, most prominently OCT4 with
SOX2. The combination of OCT4 and SOX2 without NANOG
scarcely occurs genome-wide (159). In contrast, the combination
OCT4, SOX2 and NANOG occurs 6698 times. The high levels of
CTCF at OCT4/SOX2 loci is therefore likely to be unspecific and
of low relevance. We further tested the enrichment of CTCF using
the stringent data set that only contains the 10% most significant
peaks (supplementary Figure S4). In this stringent data set, CTCF
levels drop below 5% for all combinations. This suggests that
CTCF enrichment is an artifact of the large data set (false positive
binding events). To see if a stringent p-value can be used to obtain
similar estimates, we calculated the conservation independently of
the binding combinations for the full and stringent data set
(Figure 6A). Less than 5% of binding events are conserved
between mouse and human in the stringent data set. This is higher
than expected. However, combinatorial binding is a more sensitive
indicator for conservation (3–5% conserved events for p-value
cutoff vs. 14–17% for combinatorial binding), probably because
many true binding sites will be lost in the stringent data set.
Interestingly, the fraction of loci within the proximal promoter
(+21000 bp) is higher for conserved binding events compared to
non-conserved binding (Figure 6C), thus suggesting that the promoter
is under stronger evolutionary constraint. However, the majority of
binding events are distant from the predicted transcription start sites.
The increased level of conservation at combinatorially bound loci is
therefore not caused by a bias towards promoter binding.
OCT4, SOX2 and NANOG binding is highly conserved at
developmental enhancers
Studies in mouse have revealed that developmental enhancers
often show high sequence conservation [14,30]. However,
Figure 4. Average H3K27ac ChIP-Seq signal in mES cells
around combinatorially bound loci. Loci bound by Oct4, Sox2
and Nanog together with Mediator are enriched in H3K27ac, a mark
associated with active enhancers (black line). In contrast, loci without
Mediator co-localization show a much weaker enrichment (red line)
suggesting that Mediator associates with active enhancers.
doi:10.1371/journal.pcbi.1002304.g004
Figure 5. Gene Set Enrichment Analysis (GSEA) of genes near
combinatorial binding events. (A) Expression of genes in mES cells
(V6.5) and differentiated cells after 14 days (14d), sorted by the signal-
to-noise ratio obtained from the GSEA software [24]. (B) The random
walk that describes the gene set enrichment over genes sorted by their
rank according to signal-to-noise ratio (similar sorting as in (A)). Set 1
(Oct4, Sox2, Nanog and Med1/Med12 in blue) is enriched in genes
active in mES cells (enrichment score 0.43, p-value=0.0), set 2 (Oct4,
Sox2, Nanog without Med1/Med12 in yellow) is enriched in genes
active in differentiated cells (enrichment score 20.3, p-value=0.05).
Combinatorial binding of Oct4, Sox2 and Nanog identifies active and
poised enhancers; Mediator is associated with active gene expression.
doi:10.1371/journal.pcbi.1002304.g005
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in vivo binding conservation [11]. Here, we observe that 26% of
combinatorially bound loci which are conserved between mouse
and human ES cells are developmental enhancers in the mouse
(supplementary Figure S5). This suggests that many enhancers
bound by OCT4, SOX2 and NANOG are developmental
Figure 6. The combination of OCT4, SOX2 and NANOG influences conservation of binding events. (A) Bars indicate the fraction of loci
where binding of Nanog, Sox2, Oct4 or CTCF can be observed at the orthologous locus in mouse ES cells for all combinations of OCT4, SOX2 and
NANOG in human ES cells as indicated by the boxes below. Dark boxes indicate binding, white boxes indicate no binding (‘‘AND’’ relation), light grey
boxes with ‘‘v’’ indicate binding of at least one factor (‘‘OR’’ relation). Combinatorial binding of OCT4, SOX2 and NANOG shows the largest fraction of
conserved binding for Oct4, Sox2 and Nanog in mouse. Again, combinatorial binding is more sensitive than a stringent control of false positives, as is
estimated by conservation at 10% most significant peaks. (B) The fractions of binding combinations in mES cells at conserved loci (for all
combinations of binding in human cells as indicated by the boxes above). Combinatorial binding of Oct4, Sox2 and Nanog in mES cells is much
higher at combinatorially bound loci in human, suggesting that combinatorial binding is conserved in evolution. (C) The fraction of proximal and
distant binding sites for conserved and non-conserved binding events, split up according to the combinations of binding as indicated by the boxes
above. The majority of conserved binding events are distant regulatory elements. Conserved binding events are more frequently in the proximal
promoter than non-conserved binding events.
doi:10.1371/journal.pcbi.1002304.g006
Combinatorial Binding in Human and Mouse ES Cells
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increased levels of H3K27ac in human fibroblast cells (Figure 7),
suggesting that many combinatorially bound enhancers in
embryonic stem cells indeed become active after differentiation.
This finding enables us for the first time to study in vitro binding
conservation at developmental enhancers between mouse and
human.
We calculated the fraction of conserved binding events for the
different combination of transcription factors, this time discrim-
inating binding events by developmental activity (Figure 8).
Strikingly, 63%, 58% and 53% of OCT4, SOX2 and NANOG
binding events are conserved in mouse at enhancers that are active
in early development (Figure 8A). This number is drastically
higher than previous estimations [10] and shows that combina-
torial binding together with developmental activity of the bound
loci are strong indicators for binding conservation in embryonic
stem cells.
The prominent difference in conservation between individual,
isolated binding events and combinatorial binding events at
enhancers which are active in multiple cell types would suggest the
existence of ‘‘gene regulatory hotspots’’ which are highly
conserved in evolution (Figure 9). These hotspots are enhancers
which recruit multiple, interacting transcription factors in
pluripotent cells where they can be in an active or poised state.
The very same element recruits different sets of transcription
factors after differentiation and during development. This complex
regulatory activity might lead to the high level of conservation that
we can observe in this study and discriminates these hotspots from
isolated transcription factor binding sites.
The element downstream of SOX21 is such an example and
illustrates the intimate connection between embryonic stem cells,
pluripotency and development (supplementary Figure S6). SOX21
plays a pivotal role during brain development by promoting
neuronal differentiation [31]. The downstream regulatory element
is ultra-conserved with high sequence similarity in human, mouse
and zebrafish, where it is always in close proximity to the SOX21
gene. The cis-regulatory element is bound by OCT4, SOX2,
NANOG and p300 in human ES cells and Oct4, Sox2, Nanog
and p300 in mouse ES cells (supplementary Figure S6A–B).
During mouse midbrain and forebrain development, this element
is bound by p300 and expression data shows that Sox21 is indeed
over expressed in forebrain compared to the whole embryo at day
11.5 [14]. The human element was tested in vivo in mouse and
showed reproducible activity in forebrain, midbrain, hindbrain
and neural tube (supplementary Figure S6C) [32]. The same
element is conserved in amphioxus where it is associated with the
Figure 7. Average Fibroblast ChIP-Seq signal profile around
loci bound by OCT4, SOX2 or NANOG in hES cells. Enhancers
bound by OCT4, SOX2 or NANOG which are active in mouse
development (red line) are enriched in H3K27ac in human fibroblast
cells (IMR90) supporting that many of these enhancers are develop-
mentally active in human as well.
doi:10.1371/journal.pcbi.1002304.g007
Figure 8. Binding conservation in embryonic stem cells is
increased at developmental enhancers. (A) Bars indicate the
fraction of loci where binding of Nanog, Sox2, Oct4 and CTCF can be
observed at the orthologous locus in mouse ES cells for all
combinations of OCT4, SOX2 and NANOG in human ES cells
discriminated by developmental activity as indicated by the boxes
below. Dark boxes indicate ‘‘AND’’ relation, light grey boxes with ‘‘v’’
indicate ‘‘OR’’ relation, ‘‘?’’ indicates no restriction. Combinatorial
binding events at developmentally active enhancers show the highest
levels of binding conservation between mouse and human ES cells
(.50%). (B) The fractions of binding combinations in mES cells at
conserved loci (for all combinations indicated by the boxes above). The
majority of conserved binding events at developmentally active
enhancers where OCT4, SOX2 and NANOG bind simultaneously show
combinatorial binding of Oct4, Sox2 and Nanog in mouse ES cells. (C)
The fraction of proximal and distant binding sites for conserved and
non-conserved binding events (split up according to the combinations
of binding as indicated by the boxes above). The majority of conserved
binding events are distant regulatory elements.
doi:10.1371/journal.pcbi.1002304.g008
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zebrafish where it showed reproducible activity in forebrain [33]
(supplementary Figure S6D). The conserved enhancer down-
stream of SOX21 is therefore a unique example of a functionally
and genetically ultra-conserved cis-regulatory element that is
bound in ES cells and active during development. This finding is
indeed remarkable as it has been estimated that amphioxus split
from vertebrates about 550 million years ago [34].
Conserved binding events are associated with genes
involved in transcriptional regulation and early
development
The outcome of transcription factor binding events is ultimately
determined by the function of the genes that they regulate. We
found 720 conserved loci bound by OCT4, SOX2 and NANOG
in human and mouse ES cells, associated with 608 genes nearby.
Amongst these putative target genes are OCT4, SOX2, LEFTY1,
JARID2 and many other well known factors associated with
pluripotency. A number of genes also show strong species-specific
binding patterns, most prominently Esrrb, an interaction partner of
Oct4 [35] which is almost exclusively bound in mouse ES cells
(supplementary Figure S7).
To obtain a more general picture of the downstream target
genes of conserved combinatorial binding events we performed a
Gene Ontology (GO) enrichment analysis using the Genomic
Regions Enrichment of Annotations Tool [36]. We selected all
combinatorially bound regions as background. The subset of
conserved combinatorially bound loci is significantly enriched in
the terms pattern specification process (p=4.7e-13), regionaliza-
tion (2.5e-12) and developmental induction (8.4e-8). Even though
the background set is already enriched in developmental GO
terms (amongst others developmental induction, p-value 2e-8), the
association of conserved combinatorial binding events with
developmental processes is even stronger. In support of this, genes
such as SOX21 [37], FGF4, NEUROG3 [38] and CDX2 [39]
which are located near conserved combinatorial binding events
have been shown to be important for directing differentiation of
ES cells. This implies that conserved combinatorial binding events
in ES cells have extensive downstream impact by controlling key
regulatory genes involved in differentiation and provides further
evidence for the tight connection between pluripotency and early
development mediated by OCT4, SOX2 and NANOG through
binding at developmental enhancers.
Discussion
The enormous amount of genome-wide binding data produced
in recent years has improved our understanding of the self-
renewing and pluripotent state of embryonic stem cells [3,5,27,40].
By integrating data from ES cells with developmental enhancers
we discovered that the very same regulatory elements bound by
key pluripotency factors in ES cells frequently act as enhancers
during early development. This finding provides an unknown link
between the gene regulatory networks of ES cells and early
development at the level of transcriptional regulation.
The finding that binding at these developmental enhancers is
highly conserved in mouse and human ES cells suggests that these
elements are crucial for the maintenance of the pluripotent state.
Nevertheless, some questions remain. Based on our data we
cannot explain why in pluripotent cells OCT4, SOX2 and
NANOG bind to enhancers which are also active at developmen-
tal stages when neither NANOG nor OCT4 are expressed. It is
likely that these elements are poised for activation [23,27], and an
open chromatin state might be maintained throughout develop-
ment to enable recruitment of transcription factors, co-activators,
or histone modification proteins throughout cellular specification.
These enhancers bound in multiple developmental stages by
multiple factors show properties of gene regulatory hotspots,
elements that influence gene expression in numerous cell types
from pluripotent cells to at least cells of the mouse embryo at day
11.5. The existence of such gene regulatory hotspots could explain
the extraordinarily high level of binding conservation observed in
ES cells, since mutations of these elements would influence a major
part of early embryogenesis. In contrast to these hotspots, loss of
individual binding events can more easily be substituted by nearby
binding events, and is likely to influence only a limited number of
cell types. Our analysis suggests that the fast evolutionary rewiring
of regulatory networks indeed mainly affects individual binding
events, while combinatorial binding at these regulatory hotspots is
under stronger evolutionary constraint.
The definition of combinatorial binding in this study relies on
ChIP-Seq technology. We define combinatorial bound loci as
genomic regions were we observe binding of different transcription
factors in similar cell types. These experiments are independent of
each other and reflect measures from a mixed population of cells.
Co-localization could therefore be observed without direct
Figure 9. Model for ‘‘gene regulatory hotspots’’. (A) Enhancers
are bound by OCT4, SOX2 and NANOG together with p300 in
embryonic stem cells. These enhancers maintain pluripotency by
activating gene expression in ES cells (top) or poisoning expression
for activation after differentiation (bottom) (B) After differentiation of
the cell, the same enhancers are bound by p300 in developmental
tissues together with other transcription factors. The target gene is
expressed. We propose that enhancers which recruit multiple
transcription factors in different stages of development are gene
regulatory hotspots which are crucial to connect the regulatory
networks of pluripotency and development. These enhancers show
higher sequence conservation compared to individual, isolated binding
events which active in single cell types.
doi:10.1371/journal.pcbi.1002304.g009
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competitive binding). However, based on the results of this and
other studies [35,41] we believe that co-localization as observed by
the ChIP-Seq technology indeed reflects combinatorial binding.
One of the difficulties in analyzing genome-wide datasets is how
to discriminate true binding sites from false positive binding sites.
It is impossible to identify a set of exclusively true binding sites, due
to technical limitations, but also due to biological variation since
many binding events will only be important under specified
developmental cues. A more stringent p-value cutoff decreases the
fraction of false binding sites in the data while at the same time
true positive binding events will be lost. Combinatorial binding is
likely to select for true binding sites as well, since non-functional
binding events are unlikely to be detected in multiple experiments
(supplementary Figure S10). However, combinatorial binding is
different from a stringent control of false positives as can be seen
by Mediator co-localization and binding conservation (Figures 3
and 6). It has been shown that groups of transcription factor
binding sites are more likely to be conserved than isolated sites
[42] which supports the value of combinatorial binding for
transcriptional regulation. This is an important insight for future
studies, which should consider the combination of transcription
factors for defining regulatory networks.
One limitation of the ChIP-Seq technology is that we cannot
exclude combinatorial binding at isolated binding events. Weak or
sporadic combinatorial binding events might be missed and
therefore wrongly assigned as individual binding events (false
negatives). We compared the results using two different cutoffs, a
loose cutoff (full data set) with few false negatives and a very
stringent cutoff (stringent data set) with many false negatives. The
results largely agree: Combinatorial binding events (OCT4,
SOX2, NANOG) consistently show the strongest association with
Mediator (supplementary Figure S2) and highest levels of binding
conservation (supplementary Figures S4 and S9). This suggests
that the influence of the p-value cutoff and false negative binding
events is limited on this analysis.
Most of the binding data in this study is obtained from
embryonic stem cells. We integrated data sets from two mouse cell
lines (V6.5 and E14). Interestingly, loci bound in both cell lines are
much more likely to show co-localization with Mediator
(supplementary Figure S8A). In human, we extended the available
data by OCT4 ChIP-Seq from embryonal carcinoma cells to
obtain data from different cell lines. We observe that, loci bound in
EC and ES cells are much more likely to show combinatorial
binding (supplementary Figure S8B). Therefore employing closely
related cell lines is a biologically relevant approach for identifying
important binding sites when data on combinatorial binding is not
available.
Developmental cues that lead to differentiation of cells during
early embryogenesis involves binding of transcription factors at
regulatory sequences in the genome. We have demonstrated that
in ES cells, the combination of transcription factors that bind to
regulatory elements is important for transcriptional activation.
Combinatorial binding of OCT4, SOX2 and NANOG identifies
enhancers characterized by H3K27ac and Mediator co-localiza-
tion. Many of these combinatorially bound enhancers are active
during early development. The comparison of mouse and human
ES cells shows that both combinatorial binding and multiple
activity of enhancers in ES cells and development increase the
evolutionary constraint. The set of conserved combinatorially
bound embryonic stem cell enhancers is available (supplementary
Table S2) and might be helpful as a set of putative human
developmental enhancers. Our analysis suggests that the fast
evolutionary rewiring of regulatory networks mainly affects
individual binding events. In contrast to these events, there is a
group of conserved enhancers in the genome which recruit
multiple interacting factors and are active in multiple tissues of the
developing embryo (Figure 9). Many of these ‘‘gene regulatory
hotspots’’ are under strong evolutionary constraints and seem to
play a major role by linking the regulatory networks of cellular
differentiation during early mammalian development.
Materials and Methods
Cell culture
NCCIT cells were grown in high-glucose DMEM supplemented
with 10% FCS (Biochrom, Berlin/Germany), 2 mM glutamine,
and penicillin/streptomycin on conventional tissue culture dishes.
Chromatin immunoprecipitation
Human NCCIT cells were grown to a final count of 5610
7–10
8
cells for each Immunoprecipitation. Cells were chemically cross-
linked by the addition of one-tenth volume of fresh 11%
formaldehyde solution for 10 minutes at room temperature. Cells
were rinsed twice with 16PBS and harvested using a silicon
scraper and flash frozen in liquid nitrogen and stored at 280uC
prior to use. Cells were resuspended, subjected to lysis buffers, and
sonicated to solubilize and shear crosslinked DNA. Sonication
conditions vary depending on cells, culture conditions, cross-
linking, and equipment. We used a BRANSON 250 and sonicated
at power 3 for 11:00 min with 30% Duty Cycle at 4uC while
samples were immersed in an ice bath. The resulting whole-cell
extract (WCE) was incubated overnight at 4uC with 100 mlo f
Dynal Protein G magnetic beads that had been pre-incubated with
either 10 mg of OCT4 antibody or a non-specific control antibody
(normal goat IgG, sc-2028).
Beads were washed five times with RIPA buffer and once with
TE containing 50 mM NaCl. Bound complexes were eluted from
the beads by heating at 65uC with occasional vortexing, and
crosslinking was reversed by overnight incubation at 65uC. Whole-
cell extract DNA (reserved from the sonication step) was also
treated for crosslink reversal. Immunoprecipitated DNA and
whole-cell extract DNA were then purified by treatment with
RNase A, proteinase K, multiple phenol:chloroform:isoamyl
alcohol extractions and precipitation with ethanol. Purified DNA
was amplified using a one-stage random PCR protocol [43].
Library preparation
Input and ChIP-Seq material was purified using QIAquick spin
columns and buffer QG (Qiagen) according to the manufacturer’s
protocol. 200 mg of fragmented DNA were subjected to single end
library preparation using the genomic DNA sample prep kit
(#FC-102-1002, Illumina) according to the manufacturer’s
instructions with the following modifications. End repair was
performed in the presence of 0,25 mM dNTPs Mix in a total
volume of 100 ml, A-tailing was performed in a total volume of
50 ml. Adapters were ligated to the DNA fragments using 10 mlo f
‘Adapter oligo mix’ and in a total reaction volume of 50 ml.
Libraries were size selected on a 2% agarose gel for fragments of
150–250 bp. After size selection, PCR comprising of 17
amplification cycles was carried out following the instructions
manual. Libraries were quantified on a Qubit fluorometer using
the QuantIt dsHS Assay Kit (Invitrogen).
Illumina Genome Analyzer sequencing
After library quantification a 10 nmol stock solution of the
amplified library was created. 4 pM of the stock solution were
loaded onto the channels of a 1.0 mm flow cell and cluster
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formed on an Illumina Genome Analyser (GAII). After quality
control of the first base incorporation (signal intensities, cluster
density) the run was started. All Chip-Seq and input samples were
subjected to 36 b single read sequencing run. Processing of the raw
data was carried out employing the Illumina 1.2 pipeline version.
The data is publicly available at the European Nucleotide Archive
(accession number ERP001004).
Data processing
Public data was downloaded in FASTQ format from the
European Nucleotide Archive. The details about the different datasets
including all accession numbers are summarized in supplementary
Table S1. We mapped reads using Bowtie (0.12.5) [44] with options
2m 1 and 2v 2 which guarantees that only those reads are kept
that map uniquely and that contain at most two mismatches when
being aligned to the reference, using hg19 and mm9 as reference
sequences, see supplementary Table S1 for the number and
percentage of mapped reads. Developmental enhancers were
obtained from Blow et al. [26].
Peak calling
We run the peak calling software MACS (1.4.0) [16] on the
resulting BED files using the control data as summarized in
supplementary Table S1. We used the MACS default parameters,
i.e. a p-value cutoff of 10
25, except for the tag and effective
genome size which had to be adjusted for every experiment and –
mfold 5,30. As a second step, we solely run MACS on every negative
control set. Using the resulting control peaks, we ‘‘cleaned’’ the
peak lists of the first step by eliminating all treatment peak regions
that overlap with these treatment-unspecific control peaks with the
help of the tool ‘‘intersectBed’’ from the BEDTools suite [45], the
resulting numbers of peaks before and after this ‘‘cleaning’’
procedure are given in supplementary Table S1.
Bioinformatics analysis
Peaks from the mouse-ChIP-Seq experiments were mapped to
the human genome using the UCSC LiftOver tool (2minmatch
0.1). All datasets were iteratively integrated by extending the
length of the combined regulatory sites to the span of overlapping
peaks. We created a binary matrix that contains for every
regulatory site and every factor a ‘1’ if it occurs at that site.
Significance of pairwise overlap of genome-wide binding profiles
was calculated using a hyper geometric test. Calculated p-values
give the probability to observe the number of shared binding
events for position-randomized data sets. We sampled from J of
the genome-size assuming a minimal overlap of 1 bp to obtain
conservative estimates of p-values. Clustering was done on z-score
obtained from the hyper geometric tests. Enrichment of histone
modifications was calculated on the highest 10% of peaks. All
analysis was carried out with R [46], Bioconductor and
peakAnalyzer. Supplementary Figure S11 shows mRNA sequenc-
ing reads 3000 bp around binding events to demonstrate that
proximal binding events are indeed associated with transcription
nearby. Supplementary Figure S12 shows the CpG content for
different binding events to demonstrate that our observations are
not biased toward CpG islands. Combinatorially bound loci in the
mouse genome are summarized in supplementary Table S3.
Supporting Information
Figure S1 Comparison of different cutoffs for peak calling. The
diagram shows the percentage of Oct4 bound loci that are bound
by Nanog and Sox2. The observed level of co-localization is very
similar across data sets with different cutoffs. (A) Full data set, all
peaks with p,e-05. (B) FDR controlled data set, peaks with p,e-
05 and FDR,2%. (C) stringent cutoff, the 10% most significant
peaks from all peaks with p,e-05.
(TIFF)
Figure S2 Mediator co-localizes with Oct4, Sox2 and Nanog at
combinatorially bound enhancers. For every data set, only the
10% most significant peaks of all peaks with p,e-05 are
considered. (A) Bars indicate the fraction of loci where Med1,
Med12 and CTCF binding can be observed, depending on the
combination of Oct4, Sox2 and Nanog, indicated by boxes below.
Dark boxes indicate binding, white boxes indicate no binding
(‘‘AND’’ relation), light grey boxes with ‘‘v’’ indicate binding of at
least one factor (‘‘OR’’ relation). Both Med1 and Med12
preferentially co-localize at loci bound by Oct4, Sox2 and Nanog
simultaneously. CTCF serves as a control to estimate unspecific
binding. (B) The majority of loci bound by Oct4, Sox2 and Nanog
are more than 1000 bp away from the nearest transcription start
sites for all possible combinations (indicated by boxes above).
Mediator co-localization mainly occurs at distant regulatory sites,
showing that the increased overlap of Med1/Med12 at combina-
torially bound loci is not caused by promoter specific co-
localization.
(TIFF)
Figure S3 Average mouse neuronal progenitor cell H3K27ac
ChIP-Seq signal profile around loci bound by Oct4, Sox2 or
Nanog in mES cells. Enhancers which are active in mouse
development are enriched in H3K27ac in neuronal progenitor cell
(red line) supporting that these elements play a role after
differentiation of embryonic stem cells.
(TIFF)
Figure S4 The combination of OCT4, SOX2 and NANOG
influences conservation of binding events. For every data set, only
the 10% most significant peaks of all peaks with p,e-05 are
considered. (A) Bars indicate the fraction of loci where binding of
Nanog, Sox2, Oct4 or CTCF can be observed at the orthologous
locus in mouse ES cells for all combinations of OCT4, SOX2 and
NANOG in human ES cells as indicated by the boxes below. Dark
boxes indicate binding, white boxes indicate no binding (‘‘AND’’
relation), light grey boxes with ‘‘v’’ indicate binding of at least one
factor (‘‘OR’’ relation). Combinatorial binding of OCT4, SOX2
and NANOG shows the largest fraction of conserved binding for
Oct4, Sox2 and Nanog in mouse. (B) The fractions of binding
combinations in mES cells at conserved loci (for all combinations
of binding in human cells as indicated by the boxes above).
Combinatorial binding of Oct4, Sox2 and Nanog in mES cells is
much higher at combinatorially bound loci in human, suggesting
that combinatorial binding is conserved in evolution. (C) The
fraction of proximal and distant binding sites for conserved and
non-conserved binding events, split up according to the combina-
tions of binding as indicated by the boxes above. The majority of
conserved binding events are distant regulatory elements.
(TIFF)
Figure S5 Conserved combinatorial binding events are active in
development. Bars indicate the fraction of loci which show
developmental activity in mouse; boxes below indicate the
combination of OCT4, SOX2 and NANOG. 25% of combina-
torial binding events which are conserved in mouse and human
are active during development.
(TIFF)
Figure S6 The ‘‘gene regulatory hotspot’’ downstream of SOX21
is functionally conserved between human, mouse and amphioxus.
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SOX21 locus with ChIP-Seq reads for the transcription factors
analyzed in this study. (B) The human sequence shows
reproducible activity in mouse development, picture taken from
the VISTA enhancer browser [32] with kind permission from L.
Pennacchio. (C) The orthologous sequence from amphioxus was
tested in zebrafish [33] where it showed reproducible activity in
forebrain. Picture in (C) reproduced with kind permission from
Genome Research.
(TIFF)
Figure S7 The ESRRB locus is bound in a highly species-specific
manner. (A) Screenshot showing the human ESRRB locus. No
significant transcription factor binding event can be observed. (B)
The orthologous locus of Esrrb in mouse shows several combina-
torial binding events (marked in red). ESRRB might play different
roles in human and mouse embryonic stem cells.
(TIFF)
Figure S8 Integrating data from different cell lines identifies
functional binding events. (A) Shown is the fraction of loci where
one, two or three (Oct4, Sox2, Nanog) transcription factor binding
events can be observed. Binding events detected in both cell lines
are more frequently bound by multiple transcription factors
(dotted lines). (B) Shown is the fraction of loci where one, two,
three or four different factors are binding (OCT4, SOX2,
NANOG, p300). The fraction of loci bound by all four factors is
much higher when data from embryonic stem cells and embryonal
carcinoma cells are combined (dotted lines).
(TIFF)
Figure S9 Binding conservation in embryonic stem cells is
increased at developmental enhancers. For every data set, only the
10% most significant peaks of all peaks with p,e-05 are
considered. (A) Bars indicate the fraction of loci where binding
of Nanog, Sox2, Oct4 and CTCF can be observed at the
orthologous locus in mouse ES cells for all combinations of OCT4,
SOX2 and NANOG in human ES cells discriminated by
developmental activity as indicated by the boxes below. Dark
boxes indicate ‘‘AND’’ relation, light grey boxes with ‘‘v’’ indicate
‘‘OR’’ relation, ‘‘?’’ indicates no restriction. Combinatorial
binding events at developmentally active enhancers show the
highest levels of binding conservation between mouse and human
ES cells (.40%). (B) The fractions of binding combinations in
mES cells at conserved loci (for all combinations indicated by the
boxes above). The majority of conserved binding events at
developmentally active enhancers where OCT4, SOX2 and
NANOG bind simultaneously show combinatorial binding of
Oct4, Sox2 and Nanog in mouse ES cells. (C) The fraction of
proximal and distant binding sites for conserved and non-
conserved binding events (split up according to the combinations
of binding as indicated by the boxes above). The majority of
conserved binding events are distant regulatory elements.
(TIFF)
Figure S10 Binding intensities for (A) NANOG, (B) OCT4 and
(C) SOX2. Combinatorial binding events show stronger binding
intensities than individual binding events, suggesting that the
number of false positives, which often show a weak signal, is
reduced at combinatorial bound loci.
(TIFF)
Figure S11 mRNA sequencing reads 3000 bp around binding
events. Binding events near annotated transcription start sites (red)
show higher levels of transcription compared to distant binding
events (green). This supports that the majority of binding events is
indeed more distant than promoters.
(TIFF)
Figure S12 The majority of binding occurs at low CpG
sequences. (A) Normalized CpG content for all loci. (B)
Normalized CpG content separated for proximal and distant
binding sites. High CpG sequences mostly occur proximal to the
transcription start sites. (C) Mediator binding mainly occurs at low
CpG sequences. (D) Combinatorial bound loci show low CpG
content.
(TIFF)
Table S1 Overview of data used in this study.
(XLS)
Table S2 Conserved combinatorially bound loci in mouse and
human (hg19).
(CSV)
Table S3 Combinatorially bound loci in mouse (mm9).
(CSV)
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